Lancet 377 (9769): 914-23, 2011.[PUBMED Abstract] Smith JW, Vukelja S, Rabe A, et al.: Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.
Breast Cancer Res Treat 142 (2): 381-8, 2013.[PUBMED Abstract] Tranum BL, McDonald B, Thigpen T, et al.: Adriamycin combinations in advanced breast cancer.
A Southwest Oncology Group Study.
Cancer 49 (5): 835-9, 1982.[PUBMED Abstract] Langley RE, Carmichael J, Jones AL, et al.: Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.